Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for anti-p200 pemphigoid has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for anti-p200 pemphigoid.
27 publications have been identified in PubMed for anti-p200 pemphigoid. Research spans Case Report / Case Series (44%), Basic Science / Preclinical (19%), and Diagnostic / Biomarker (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 44% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:04 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
5 |
19% |
Testing and diagnosis research | 3 | 11% |
Research summaries | 3 | 11% |
Disease patterns and progression | 3 | 11% |
New treatment approaches | 1 | 4% |
Kasperkiewicz M (2026). [PMID: 40853220](https://pubmed.ncbi.nlm.nih.gov/40853220/). *The British journal of dermatology*. [Review / Meta-Analysis]
Emtenani S (2026). [PMID: 41750253](https://pubmed.ncbi.nlm.nih.gov/41750253/). *Biomolecules*. [Diagnostic / Biomarker]
Ancker G (2026). [PMID: 41563431](https://pubmed.ncbi.nlm.nih.gov/41563431/). *Dermatologie (Heidelberg, Germany)*. [Basic Science / Preclinical]
Kohri N (2026). [PMID: 41126732](https://pubmed.ncbi.nlm.nih.gov/41126732/). *The Journal of dermatology*. [Case Report / Case Series]
Gerhardt F (2026). [PMID: 41493552](https://pubmed.ncbi.nlm.nih.gov/41493552/). *Dermatologie (Heidelberg, Germany)*. [Case Report / Case Series]
Jouen F (2026). [PMID: 41793217](https://pubmed.ncbi.nlm.nih.gov/41793217/). *Journal of the European Academy of Dermatology and Venereology : JEADV*. [Epidemiology / Natural History]
Suo L (2026). [PMID: 41367347](https://pubmed.ncbi.nlm.nih.gov/41367347/). *The Australasian journal of dermatology*. [Epidemiology / Natural History]
Wellman EA (2026). [PMID: 41974588](https://pubmed.ncbi.nlm.nih.gov/41974588/). *Pediatr Dermatol*. [Case Report / Case Series]
Koga H (2025). [PMID: 39488782](https://pubmed.ncbi.nlm.nih.gov/39488782/). *The Journal of investigative dermatology*. [Basic Science / Preclinical]
Wang Y (2025). [PMID: 39160661](https://pubmed.ncbi.nlm.nih.gov/39160661/). *International journal of dermatology*. [Basic Science / Preclinical]
AI-curated news mentioning anti-p200 pemphigoid
Updated Mar 7, 2026
A nationwide study has been conducted to determine the incidence of P200 pemphigoid, contributing valuable data to the understanding of this rare disease. The findings may help inform future research and treatment strategies.